{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T04:24:32Z","timestamp":1743740672071,"version":"3.30.2"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Tuberculosis and Other Mycobacterial Diseases"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jctube.2024.100471","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T23:52:55Z","timestamp":1722037975000},"page":"100471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Investigating the efficacy of integrating video-directly observed therapy (VDOT) in the treatment of tuberculosis (TB): A statewide analysis from Florida"],"prefix":"10.1016","volume":"37","author":[{"given":"Aneesha","family":"Raj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabiha S.","family":"Khakoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex A.","family":"Ashkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary T.","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rene R.","family":"Tresgallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jctube.2024.100471_b0005","unstructured":"Tuberculosis. World Health Organization. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/tuberculosis. Published November 7, 2023."},{"key":"10.1016\/j.jctube.2024.100471_b0010","unstructured":"Global Tuberculosis Report 2020. World Health Organization. https:\/\/www.who.int\/publications\/i\/item\/9789240013131. Published October 15,2020."},{"key":"10.1016\/j.jctube.2024.100471_b0015","unstructured":"Treatment for TB Disease. Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/tb\/topic\/treatment\/tbdisease.htm. Updated March 22, 2023."},{"key":"10.1016\/j.jctube.2024.100471_b0020","unstructured":"Recommendations for Use of Video Directly Observed Therapy During Tuberculosis Treatment. Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/mmwr\/volumes\/72\/wr\/mm7212a4.htm. Updated March 24, 2023."},{"key":"10.1016\/j.jctube.2024.100471_b0025","unstructured":"Treating Active Tuberculosis Disease. Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/tb\/treatment\/active-tuberculosis-disease.html. Updated May 6, 2024."},{"key":"10.1016\/j.jctube.2024.100471_b0030","unstructured":"Implementing the End TB Strategy. World Health Organization. https:\/\/www.who.int\/westernpacific\/activities\/implementing-the-end-tb-strategy. Accessed 24 January 2023."},{"issue":"1","key":"10.1016\/j.jctube.2024.100471_b0035","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1186\/s12879-016-1862-y","article-title":"Does directly observed therapy improve tuberculosis treatment? More evidence is needed to guide tuberculosis policy","volume":"16","author":"McLaren","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.jctube.2024.100471_b0040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/cid\/cit167","article-title":"A meta-analysis of self-administered vs directly observed therapy effect on microbiologic failure, relapse, and acquired drug resistance in tuberculosis patients","volume":"57","author":"Pasipanodya","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.jctube.2024.100471_b0045","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.5588\/ijtld.13.0867","article-title":"Effectiveness of directly observed treatment of tuberculosis: a systematic review of controlled studies","volume":"18","author":"Tian","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jctube.2024.100471_b0050","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003343.pub3","article-title":"Directly observed therapy for treating tuberculosis","volume":"4","author":"Volmink","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.jctube.2024.100471_b0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014014","article-title":"Patients\u2019 costs and cost-effectiveness of tuberculosis treatment in DOTS and non-DOTS facilities in Rio de Janeiro, Brazil","volume":"5","author":"Steffen","year":"2010","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jctube.2024.100471_b0060","doi-asserted-by":"crossref","first-page":"e0119861","DOI":"10.1371\/journal.pone.0119861","article-title":"Assessing the consequences of stigma for tuberculosis patients in urban Zambia","volume":"10","author":"Cremers","year":"2015","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.jctube.2024.100471_b0065","first-page":"741","article-title":"Feasibility of home-based and health centre-based DOT: perspectives of TB care providers and clients in an HIV-endemic area of Thailand","volume":"5","author":"Ngamvithayapong","year":"2001","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jctube.2024.100471_b0070","article-title":"Synchronous and asynchronous video observed therapy (VOT) for tuberculosis treatment adherence monitoring and support","volume":"17","author":"Garfein","year":"2019","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"issue":"11","key":"10.1016\/j.jctube.2024.100471_b0075","doi-asserted-by":"crossref","first-page":"e50155","DOI":"10.1371\/journal.pone.0050155","article-title":"Home videophones improve direct observation in tuberculosis treatment: a mixed methods evaluation","volume":"7","author":"Wade","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jctube.2024.100471_b0080","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijid.2017.09.029","article-title":"Video Directly Observed Therapy to support adherence with treatment for tuberculosis in Vietnam: a prospective cohort study","volume":"65","author":"Nguyen","year":"2017","journal-title":"Int J Infect Dis"},{"issue":"10177","key":"10.1016\/j.jctube.2024.100471_b0085","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S0140-6736(18)32993-3","article-title":"Smartphone-enabled video-observed versus directly observed treatment for tuberculosis: a multicentre, analyst-blinded, randomised, controlled superiority trial","volume":"393","author":"Story","year":"2019","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jctube.2024.100471_b0090","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00493-2020","article-title":"Video-observed therapy and medication adherence for tuberculosis patients: randomised controlled trial in Moldova","volume":"56","author":"Ravenscroft","year":"2020","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.jctube.2024.100471_b0095","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.44210","article-title":"In-person vs electronic directly observed therapy for tuberculosis treatment adherence: a randomized noninferiority trial","volume":"5","author":"Burzynski","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"9","key":"10.1016\/j.jctube.2024.100471_b0100","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1089\/tmj.2019.0190","article-title":"Telemedicine technologies and tuberculosis management: a randomized controlled trial","volume":"26","author":"Guo","year":"2020","journal-title":"Telemed JE Health"},{"issue":"11","key":"10.1016\/j.jctube.2024.100471_b0105","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.5588\/ijtld.18.0625","article-title":"Cost savings associated with video directly observed therapy for treatment of tuberculosis","volume":"23","author":"Lam","year":"2019","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"10.1016\/j.jctube.2024.100471_b0110","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1183\/09031936.00011015","article-title":"Video directly observed therapy for treatment of tuberculosis is patient-oriented and cost-effective","volume":"46","author":"Mirsaeidi","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jctube.2024.100471_b0115","unstructured":"Electronic Directly Observed Therapy for Active TB Disease. Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/nchhstp\/highimpactprevention\/promising-hip-intervention.html.Updated April 12, 2023."},{"issue":"43","key":"10.1016\/j.jctube.2024.100471_b0120","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.15585\/mmwr.mm6943a3","article-title":"Trends in the use of telehealth during the emergence of the COVID-19 pandemic - United States, January-March 2020","volume":"69","author":"Koonin","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jctube.2024.100471_b0125","unstructured":"Kara GC, Yalcin BM. Comparison of In-Person vs. Video Directly Observed Therapy (VDOT) on Stigma Levels in Tuberculosis Patients. J Am Board Fam Med. Published online August 25, 2022:jabfm.2022.AP.210514. doi:10.3122\/jabfm.2022.AP.210514."},{"issue":"4","key":"10.1016\/j.jctube.2024.100471_b0130","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy046","article-title":"Advancing patient-centered care in tuberculosis management: a mixed-methods appraisal of video directly observed therapy","volume":"5","author":"Holzman","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jctube.2024.100471_b0135","doi-asserted-by":"crossref","unstructured":"TB\/COVID-19 Global Study Group. Tuberculosis and COVID-19 co-infection: description of the global cohort. Eur Respir J. 2022;59(3):2102538. doi:10.1183\/13993003.02538-2021.","DOI":"10.1183\/13993003.02538-2021"},{"key":"10.1016\/j.jctube.2024.100471_b0140","unstructured":"Reported Tuberculosis in the United States, 2021. Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/tb\/statistics\/reports\/2021\/state_local_data.htm. Updated November 29, 2022."}],"container-title":["Journal of Clinical Tuberculosis and Other Mycobacterial Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405579424000585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405579424000585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T11:41:02Z","timestamp":1733917262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405579424000585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":28,"alternative-id":["S2405579424000585"],"URL":"https:\/\/doi.org\/10.1016\/j.jctube.2024.100471","relation":{},"ISSN":["2405-5794"],"issn-type":[{"type":"print","value":"2405-5794"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigating the efficacy of integrating video-directly observed therapy (VDOT) in the treatment of tuberculosis (TB): A statewide analysis from Florida","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jctube.2024.100471","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100471"}}